The Valley Desk

NCT06856577 · Interventional trial

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Overall registry status Active not recruiting

Phase 3

Conditions Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov